Root Financial Partners
KROS icon

Root Financial Partners’s Keros Therapeutics KROS Stock Holding History

Root Financial Partners’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.22K Buy
+195
New +$2.13K ﹤0.01% 2595

Other funds holding KROS

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Root Financial Partners's KROS Position: Q3 2026 in Review

Root Financial Partners opened a new position in Keros Therapeutics (KROS) in Q3 2026: 195 shares worth $2.22K. The stake represents ﹤0.01% of the portfolio and ranks #2595 among its holdings.

9 funds tracked by Wall St. Rank hold KROS as of Q3 2026.

  • Root Financial Partners held 195 shares of Keros Therapeutics worth $2.22K as of Q3 2026.
  • Keros Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Keros Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2595 holding.
  • 9 funds tracked by Wall St. Rank held Keros Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.